ArticleTargeted oncology2018
Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors.
Karima Saboundji et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled ittrialcites it